Literature DB >> 24736403

Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.

Clara Steichen1, Eléanor Luce1, Jérôme Maluenda1, Lucie Tosca1, Inmaculada Moreno-Gimeno1, Christophe Desterke1, Noushin Dianat1, Sylvie Goulinet-Mainot1, Sarah Awan-Toor1, Deborah Burks1, Joëlle Marie1, Anne Weber1, Gérard Tachdjian1, Judith Melki1, Anne Dubart-Kupperschmitt2.   

Abstract

The use of synthetic messenger RNAs to generate human induced pluripotent stem cells (iPSCs) is particularly appealing for potential regenerative medicine applications, because it overcomes the common drawbacks of DNA-based or virus-based reprogramming strategies, including transgene integration in particular. We compared the genomic integrity of mRNA-derived iPSCs with that of retrovirus-derived iPSCs generated in strictly comparable conditions, by single-nucleotide polymorphism (SNP) and copy number variation (CNV) analyses. We showed that mRNA-derived iPSCs do not differ significantly from the parental fibroblasts in SNP analysis, whereas retrovirus-derived iPSCs do. We found that the number of CNVs seemed independent of the reprogramming method, instead appearing to be clone-dependent. Furthermore, differentiation studies indicated that mRNA-derived iPSCs differentiated efficiently into hepatoblasts and that these cells did not load additional CNVs during differentiation. The integration-free hepatoblasts that were generated constitute a new tool for the study of diseased hepatocytes derived from patients' iPSCs and their use in the context of stem cell-derived hepatocyte transplantation. Our findings also highlight the need to conduct careful studies on genome integrity for the selection of iPSC lines before using them for further applications. ©AlphaMed Press.

Entities:  

Keywords:  Genome integrity; Hepatic differentiation; SNP/CNV analysis; iPSCs; mRNA reprogramming

Mesh:

Substances:

Year:  2014        PMID: 24736403      PMCID: PMC4039453          DOI: 10.5966/sctm.2013-0158

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  21 in total

1.  Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development.

Authors:  Thomas Touboul; Nicholas R F Hannan; Sébastien Corbineau; Amélie Martinez; Clémence Martinet; Sophie Branchereau; Sylvie Mainot; Hélène Strick-Marchand; Roger Pedersen; James Di Santo; Anne Weber; Ludovic Vallier
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

2.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

Authors:  Yoav Mayshar; Uri Ben-David; Neta Lavon; Juan-Carlos Biancotti; Benjamin Yakir; Amander T Clark; Kathrin Plath; William E Lowry; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

3.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

4.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

5.  Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma.

Authors:  Matthew J Ferber; Erik C Thorland; Antoinette A T P Brink; Anton K Rapp; Leslie A Phillips; Renee McGovern; Bobbie S Gostout; Tak Hong Cheung; Tong Kwok Hung Chung; Wong Yick Fu; David I Smith
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

Review 6.  Concise review: clinical programs of stem cell therapies for liver and pancreas.

Authors:  Giacomo Lanzoni; Tsunekazu Oikawa; Yunfang Wang; Cai-Bin Cui; Guido Carpino; Vincenzo Cardinale; David Gerber; Mara Gabriel; Juan Dominguez-Bendala; Mark E Furth; Eugenio Gaudio; Domenico Alvaro; Luca Inverardi; Lola M Reid
Journal:  Stem Cells       Date:  2013-10       Impact factor: 6.277

7.  Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.

Authors:  Christine Wasylyk; Hong Zheng; Christelle Castell; Laurent Debussche; Marie-Christine Multon; Bohdan Wasylyk
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

8.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

View more
  13 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 3.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

4.  An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomy.

Authors:  Clara Steichen; Jérôme Maluenda; Lucie Tosca; Eléanor Luce; Dominique Pineau; Noushin Dianat; Zara Hannoun; Gérard Tachdjian; Judith Melki; Anne Dubart-Kupperschmitt
Journal:  Stem Cells Transl Med       Date:  2015-02-03       Impact factor: 6.940

5.  Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor.

Authors:  Estelle Oberlin; Hind Guenou; Alejandra Vargas-Valderrama; Anne-Charlotte Ponsen; Morgane Le Gall; Denis Clay; Sébastien Jacques; Tudor Manoliu; Valérie Rouffiac; Karine Ser-le-Roux; Cyril Quivoron; Fawzia Louache; Georges Uzan; Maria-Teresa Mitjavila-Garcia
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

Review 6.  mRNA-Based Genetic Reprogramming.

Authors:  Luigi Warren; Cory Lin
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

7.  Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.

Authors:  Noushin Dianat; Hélène Dubois-Pot-Schneider; Clara Steichen; Christophe Desterke; Philippe Leclerc; Aurélien Raveux; Laurent Combettes; Anne Weber; Anne Corlu; Anne Dubart-Kupperschmitt
Journal:  Hepatology       Date:  2014-06-20       Impact factor: 17.425

8.  Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells.

Authors:  Karl Gledhill; Zongyou Guo; Noriko Umegaki-Arao; Claire A Higgins; Munenari Itoh; Angela M Christiano
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 9.  mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.

Authors:  Palas K Chanda; Roman Sukhovershin; John P Cooke
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

Review 10.  Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes.

Authors:  Eléanor Luce; Antonietta Messina; Jean-Charles Duclos-Vallée; Anne Dubart-Kupperschmitt
Journal:  Hepatology       Date:  2021-08-22       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.